Product | Target | Administration | Reference |
|---|
Teclistamab | BCMA × CD3 | SC | [1] |
Elranatamab | BCMA × CD3 | SC | [4] |
Linvoseltamab | BCMA × CD3 | IV | [7] |
F182112 | BCMA × CD3 | IV | [8] |
Talquetamab | GPRC5D × CD3 | SC | [9] |
Cevostamab | FcRH5 × CD3 | IV | [13] |
- Abbreviations: BCMA, B-cell maturation antigen; bsAbs, bispecific antibodies; FcRH5, Fc receptor-homolog 5; GPRC5D, G protein-coupled receptor family C group 5 member D; IV, intravenous; SC, subcutaneous
